ÃâÒßѧÊÔÌâ
R0qZxoo Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
\ UrD%;sq 1. Fas(CD95)/FasL
q~}oU5 2. common chain of cytokine receptor
nms[No? 3 . TCR/CD3 complex
|~5cNm 4. negaive selection of thymocytes
#ELeW3
S} 5. artificial active immune
[e` |< 6. anti-idiotypic
R:f!ywj% 7. IgSF
W+a/>U 8. Integrin
w8X5kk
9. chemokine
inU5eronuj 10. B7/CD28
/[_aK0U3 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
F:m6Mf7L 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
dXxf{|gk> 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
S%MDQTM 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
H/{@eaV 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
/C8 }5)
JxinfWk
1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
~qqxHymc µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
Z5v_- +K Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
RK.lzVaY 1. B7/CD28
BX$<5S@ 2. Th1 subset
?w(hPUd!2 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
1\(
N,'h 4. antibody affinity maturation
RVAku 5. AP-1
?'~u)O(n 6. single chain variable fragment£¨ScFv£©
= vqJ0 ! 7. NK cell receptor
d2eXN3" 8. Zinkernagel-Doherty phenomenon
L'Cd`.yVO 9. Ig fold
BlpyE[h
T 10. CD40/CD40L
LC]0c)v# ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
=!L}/Dl 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
1av#u:jy~> 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
SLEOcOAmD 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
C5^WJ
x[ Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
xY]q[a?cy 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
Jw5@#j 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
,oH\rrglf 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
)A*53>JV Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
p^ (Z £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
U+'zz#0qN Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
mTsyVji8 1.Co-stimulators (or co-stimulating molecules)
Fk49~z 2.NK-kB
H_@6!R2 3.Immunoglobulin superfamily
1|8Bv0-b 4.antigen-presenting cell (APC)
B?&0NpVD 5.death domain
Y7+c/co 6.CCR and CXCR
d1_kw
A2y 7.Lectin (or mitogen)
ym5@SBqIx 8.Clusters of differentiation, CD)
&Ih }" 9.B7 family
<ot`0 10.Cytotoxic T lymphocyte, CTL)
tJu:N'=Dy 11.IL-15 and IL-15 receptor (IL-15R)
cZ)JvU9] 12.MHC restriction
Ps.xY;Y 13.Affinity-chromatography
z*.G0DFw 14.Cyctosprin A, CsA
cvy
5|;-u 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
V+D5<nICr ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
?8kFAf~ 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
Y$XzZ>VW 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
0xDn! 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
sg-^ oy*^ Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
;39a` ÃâÒßѧרҵ£º
jNx{*2._r 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
@su<_m6' Ïû»¯ÄÚ¿Æ£º
_)<5c! 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
M
2|
k. ѪҺ²¡Ñ§×¨Òµ£º
ZzBaYoNy[0 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
CvRCcSJM\2 Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
`D=OEc (רҵ»ù´¡: ÃâÒßѧ)
H0tu3Pqk Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
~
M*
UMF^ 1. ADCC(antibody dependent cell-mediated cytotoxicity)
,F->*= 2. »·æß¾úËØ(cyclosporin)
n~
$S 3. KIR(killer cell inhibitory receptor)
!Z
>,dN 4. HLDA(human leucocyte differentiation antigen)
&k| EG![ 5. Interleukin 18(IL-18)
p q?# X0 6. ÕûºÏËØ(integrin)
jTqJ(M}L 7. Fas/FasL
rtJ@D2Hj^ 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
h
`! 4`eI 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
gA_oJW4_ 10. Th1/Th2
!7~4`D
c6U 11. »ùÒòÒßÃç(DNAÒßÃç)
2vB,{/GXP 12. chemokines and chemokine receptor
^y ', l 13. ÃâÒßÄÍÊÜ
=>>Dnp 14. ¹²´Ì¼¤·Ö×Ó
lMW6D0^ 15. ËÀÍö½á¹¹Óò(death domain)
i@P=*lLD ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
G+sB/l" 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
o6 NmDv5 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
NE`;=26c £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
=&-.] |t £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
Dz.kJ_"Ro
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
R.*
k7-(; £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
[Z'4YXS 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
liB~vdqj Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
`m_fi ÎÊ´ðÌâ(ÿÌâ25·Ö)
LfrjC@
_y 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
b!SIs* 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
?JRfhJ:j 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
]+^4Yq>2 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£